Articles by L. M Zehngebot (1)

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)

M. A Socinski, M. N Saleh, D. F Trent, T. W Dobbs, L. M Zehngebot, M. A Levine, R Bordoni and P. J. Stella

Annals of Oncology 20 ( 6 ): 1068 - 1073 , 2009

Do you have a suggestion for journals

Suggest Journal